Kelly Yoo | Medicine | Best Researcher Award

Posted on by ScienceFather

Dr. Kelly Yoo | Medicine | Best Researcher Award

Clinician Scientist at Stanford University, United States

Summary:

Dr. Kelly Yoo, M.D., Ph.D., is a distinguished neurosurgeon and postdoctoral fellow at Stanford University School of Medicine. She began her education at Yeomdong Elementary School in Seoul, South Korea, where she was recognized as a top student in the gifted class. She continued her studies at the International School of Hamburg in Germany, earning an International Baccalaureate (IB) Diploma with distinction. Dr. Yoo pursued her medical education at Heidelberg University School of Medicine, excelling academically and completing her MD/PhD program with top honors. Her doctoral research focused on enhancing CAR T cell therapy for B cell malignancies, earning her a Magna cum laude distinction. Dr. Yoo’s residency training includes positions at Heidelberg University Hospital, Klinikum of Ludwig-Maximilians-University of Munich, and University Medical Center Freiburg, consistently ranking among the top of her peers. Since September 2022, she has been advancing her research and clinical expertise as a postdoctoral fellow at Stanford. In addition to her medical career, Dr. Yoo is dedicated to mentoring and teaching, having co-founded MedSchool Mentor to support future medical professionals. Her contributions to education and research have established her as a prominent figure in neurosurgery and oncology.

Profile:

Education:

Dr. Kelly Yoo began her academic journey at Yeomdong Elementary School in Seoul, South Korea, where she was a school representative and part of the gifted class with an IQ of 145, earning a Certificate of Distinction for being in the top 0.1%. She continued her education at Yeomgyeong Middle School, also in Seoul, before moving to Germany to attend the International School of Hamburg. There, she completed the International Baccalaureate (IB) Diploma, received a Certificate of Distinction for being in the top 0.1%, and participated in grade acceleration and gifted education. Dr. Yoo pursued her medical studies at Heidelberg University School of Medicine from October 2012 to October 2019. She excelled in her academic performance, consistently ranking in the top 1% of her class and achieving top 10% marks in her medical state examinations. She completed the MD/PhD Program at Heidelberg University, earning her German Medical License (Approbation) in November 2019. Her doctoral research at the Department of Internal Medicine V / Hematology Oncology at Heidelberg University Hospital focused on tumor-specific reactive oxygen species accelerators to improve Chimeric Antigen Receptor (CAR) T cell therapy in B cell malignancies, for which she received a Magna cum laude distinction. Additionally, Dr. Yoo furthered her education through various programs and internships at Johns Hopkins University, Seoul National University Hospital, and Thoraxklinik at Heidelberg University Hospital, among others.

Professional Experience:

Dr. Kelly Yoo has built an impressive professional career in neurosurgery and oncology. She began her residency in neurosurgery at Kopfklinik, Heidelberg University Hospital (UKHD), where she ranked in the top 1% of her peers. She then completed a residency in radiation oncology at Klinikum of Ludwig-Maximilians-University of Munich, achieving top 10% recognition. Returning to neurosurgery, she pursued further residency training at University Medical Center Freiburg (UKF), where she distinguished herself in the top 0.1%. Since September 2022, Dr. Yoo has been a postdoctoral fellow in the Department of Neurosurgery at Stanford University School of Medicine. In this role, she continues to advance her research and clinical expertise, contributing to cutting-edge developments in neurosurgery. Her dedication to excellence is evident throughout her career, from her clinical practice to her commitment to mentoring and teaching the next generation of medical professionals.

Research Interest:

Dr. Kelly Yoo’s research interests are deeply rooted in advancing the fields of neurosurgery and oncology. Her doctoral research focused on enhancing Chimeric Antigen Receptor (CAR) T cell therapy for B cell malignancies by using tumor-specific reactive oxygen species accelerators, a project that earned her a Magna cum laude distinction. She is particularly interested in the intersection of immunotherapy and neurosurgery, aiming to develop innovative treatments that improve patient outcomes in malignant and non-malignant brain disorders. At Stanford University, Dr. Yoo continues to explore cutting-edge therapies and techniques, with a commitment to translating her research findings into clinical applications that can benefit patients globally. Her work is characterized by a dedication to precision medicine and the use of advanced neuroimaging and neuromonitoring technologies to enhance the effectiveness and safety of neurosurgical procedures.

Awards and Honors:

Dr. Kelly Yoo has garnered numerous awards and honors throughout her distinguished career. In her early education, she was recognized as part of the gifted class at Yeomdong Elementary School and received a Certificate of Distinction for being in the top 0.1% of her peers. During her high school years at the International School of Hamburg, she earned another Certificate of Distinction for her exceptional performance in the International Baccalaureate (IB) program. Her academic excellence continued at Heidelberg University School of Medicine, where she consistently ranked in the top 1% of her class and achieved top 10% marks in her medical state examinations. Her groundbreaking doctoral research on enhancing CAR T cell therapy for B cell malignancies earned her a Magna cum laude distinction. In her professional career, Dr. Yoo received Certificates of Empowerment for being among the top residents at Kopfklinik, Heidelberg University Hospital, Klinikum of Ludwig-Maximilians-University of Munich, and University Medical Center Freiburg. These accolades reflect her outstanding contributions to neurosurgery and oncology, underscoring her dedication to clinical excellence and innovative research.

Publication:

The Role of CyberKnife Stereotactic Radiosurgery in Recurrent Cranial Medulloblastomas across Pediatric and Adult Populations

  • Authors: K.H. Yoo, N.J. Marianayagam, D.J. Park, … A. Meola, S.D. Chang
  • Journal: Journal of Clinical Medicine
  • Year: 2024
  • Volume: 13(12)
  • Page: 3592
  • Citations: 0

Therapeutic approaches for spinal synovial sarcoma: a comprehensive review of the literature

  • Authors: A. Zamarud, S. Shahnoor, A. Maryyum, … D.J. Park, S.D. Chang
  • Journal: Journal of Neurosurgery: Spine
  • Year: 2024
  • Volume: 40(6)
  • Pages: 782-789
  • Citations: 0

Surgery and stereotactic radiosurgery for spinal leiomyosarcoma: a single-institution retrospective series and systematic review

  • Authors: A. Zamarud, N.J. Marianayagam, V. Sekar, … S.D. Chang, A. Meola
  • Journal: Journal of Neurosurgery: Spine
  • Year: 2024
  • Volume: 40(4)
  • Pages: 485-497
  • Citations: 0

Stereotactic Radiosurgery for Cranial and Spinal Hemangioblastomas: A Single-Institution Retrospective Series

  • Authors: K.H. Yoo, D.J. Park, N.J. Marianayagam, … S.D. Chang, A. Meola
  • Journal: Neurosurgery
  • Year: 2024
  • Volume: 94(3)
  • Pages: 630-642
  • Citations: 1

Evaluating Computer Vision, Large Language, and Genome-Wide Association Models in a Limited Sized Patient Cohort for Pre-Operative Risk Stratification in Adult Spinal Deformity Surgery

  • Authors: E. Schonfeld, A. Pant, A. Shah, … G. Haider, A. Veeravagu
  • Journal: Journal of Clinical Medicine
  • Year: 2024
  • Volume: 13(3)
  • Page: 656
  • Citations: 0

The outcome of central nervous system hemangioblastomas in Von Hippel-Lindau (VHL) disease treated with belzutifan: a single-institution retrospective experience

  • Authors: A. Zamarud, N.J. Marianayagam, D.J. Park, … A. Meola, S.D. Chang
  • Journal: Journal of Neuro-Oncology
  • Year: 2023
  • Volume: 165(2)
  • Pages: 373-379
  • Citations: 2

Stereotactic Radiosurgery for Medically Refractory Trigeminal Neuralgia Secondary to Stroke: A Systematic Review and Clinical Case Presentation

  • Authors: A. Zamarud, D.J. Park, T.H. Ung, … S.D. Chang, A. Meola
  • Journal: World Neurosurgery
  • Year: 2023
  • Volume: 179
  • Pages: e366-e373
  • Citations: 1

Optimizing the synergy between stereotactic radiosurgery and immunotherapy for brain metastases

  • Authors: K.H. Yoo, D.J. Park, J.H. Choi, … A. Meola, S.D. Chang
  • Journal: Frontiers in Oncology
  • Year: 2023
  • Volume: 13
  • Article: 1223599
  • Citations: 3

Stereotactic radiosurgery for distant brain metastases secondary to esthesioneuroblastoma: a single-institution series

  • Authors: A. Zamarud, U. Yener, K.H. Yoo, … S.D. Chang, A. Meola
  • Journal: Neurosurgical Focus
  • Year: 2023
  • Volume: 55(2)
  • Article: E6
  • Citations: 1

Stereotactic radiosurgery for sarcoma metastases to the brain: a single-institution experience

  • Authors: A. Zamarud, D.J. Park, D.Y.A. Dadey, … S.D. Chang, A. Meola
  • Journal: Neurosurgical Focus
  • Year: 2023
  • Volume: 55(2)
  • Article: E7
  • Citations: 1

 

Haymanot Tewabe | Health Award | Best Researcher Award

Posted on by ScienceFather

Mr. Haymanot Tewabe, Health Award, Best Researcher Award

Haymanot Tewabe at Debre Markos University, Ethiopia

Mr. Haymanot Tewabe is a dedicated professional with a background in clinical laboratory science and education. He holds a Master’s degree in Clinical Laboratory Science (Clinical Chemistry) from Addis Ababa University, where he achieved an impressive CGPA of 3.93 out of 4. Prior to his master’s degree, Mr. Tewabe completed his Bachelor’s degree in Medical Laboratory Science at Jimma University, attaining a CGPA of 3.45 out of 4. Additionally, he pursued a Higher Diploma in Teacher Education at Debre Markos University.

Throughout his career, Mr. Tewabe has gained valuable experience in medical laboratory settings, having worked as both a Junior and Senior Medical Laboratory Technologist at Shegaw Motta Y/Hospital and Janmeda Health Center, respectively. Currently, he serves as a Lecturer at Debre Markos University, where he shares his expertise with aspiring healthcare professionals.

Profile:

Education:

MSc Degree in Clinical Laboratory Science (Clinical Chemistry)

  • Educational Institution: Addis Ababa University, Ethiopia
  • Duration: September 2018 – July 2020
  • CGPA: 3.93/4 (98.25%)

BSc Degree in Medical Laboratory Science

  • Educational Institution: Jimma University, Ethiopia
  • Duration: September 2011 – July 2015
  • CGPA: 3.45/4 (86.25%)

Higher Diploma in Teacher Education

  • Educational Institution: Debre Markos University, Ethiopia
  • Duration: September 2022 – July 2023, pass

Professional Experience:

Mr. Haymanot Tewabe has garnered extensive professional experience in the field of clinical laboratory science and education. His journey began as a Junior Medical Laboratory Technologist at Shegaw Motta Y/Hospital in Motta, Ethiopia, from July 2015 to October 2015, where he honed his skills in laboratory diagnostics and management. Subsequently, he served as a Senior Medical Laboratory Technologist at Janmeda Health Center in Addis Ababa, Ethiopia, from October 2015 to October 2017, assuming greater responsibilities in laboratory operations and quality assurance. Transitioning into academia, Mr. Tewabe currently holds the position of Lecturer at Debre Markos University in Ethiopia, a role he has held since October 2017. In addition to his teaching responsibilities, he actively contributes to various management and committee positions, such as Clinical Chemistry Team Unit Leader and Curriculum Revision Committee Member. Through his diverse professional experiences, Mr. Haymanot Tewabe has demonstrated a strong commitment to advancing healthcare and education standards in his community.

Research Interest:

Mr. Haymanot Tewabe’s research interests encompass a broad spectrum within the field of clinical laboratory science and education. He is particularly interested in exploring innovative approaches to clinical diagnostics, with a focus on clinical chemistry and laboratory medicine. His research endeavors may involve investigating novel biomarkers for disease detection, exploring the role of laboratory testing in disease monitoring and management, and optimizing laboratory methodologies for improved patient care.

Furthermore, Mr. Tewabe is passionate about educational research, aiming to enhance teaching and learning practices in clinical laboratory science programs. He may delve into topics such as curriculum development, instructional strategies, and assessment methods tailored to the needs of aspiring healthcare professionals. Additionally, he may explore the integration of technology and simulation-based training in laboratory education to ensure the competency and readiness of future laboratory professionals.

Overall, Mr. Haymanot Tewabe’s research interests reflect his commitment to advancing both the practice of clinical laboratory science and the quality of education in the field, with the ultimate goal of contributing to improved healthcare outcomes and the development of skilled laboratory professionals.

Publication Top Noted:

  • Authors: H. Tewabe, A. Mitiku, H. Worku
  • Journal: Journal of Blood Medicine
  • Pages: 171-180
  • Volume: 13
  • Year: 2022
  • Citations: 7

Title: Magnitude and associated factors of urinary tract infections among adults living with HIV in Ethiopia. Systematic review and meta-analysis

  • Authors: MY Birhanu, SD Habtegiorgis, W Gietaneh, S Alemu, TB Tsegaye, …
  • Journal: Plos One
  • Volume: 17
  • Issue: 4
  • Pages: e0264732
  • Year: 2022
  • Citations: 4

Title: Preparation of in-house quality control human serum for urea and its use in clinical chemistry

  • Authors: B Haile, D Bikila, H Tewabe, M Wolde
  • Journal: Clin Lab
  • Volume: 66
  • Issue: 3
  • Pages: 365-368
  • Year: 2020
  • Citations: 4

Title: Prevalence of Dental Caries of Streptococcus mutans among Diabetic Patients Who are Attending Jimma University Specialized Hospital Dental Clinic, South-West, Jimma, Ethiopia

  • Authors: H Tewabe, B Haile
  • Journal: J Clin Immunol Microbiol
  • Volume: 1
  • Issue: 2
  • Pages: 1-14
  • Year: 2020
  • Citations: 2

Title: Effect of thyroid dysfunction on hematological profiles at Menelik II Referral Hospital, Addis Ababa, Ethiopia

  • Authors: H Tewabe, A Mitiku, A Abebaw
  • Year: 2021

Wolnei Caumo | Medical award | Best Researcher Award

Posted on by ScienceFather

Prof Dr. Wolnei Caumo, Medical Award, Best Researcher Award

Professor at UFRGS, Brazil

Prof. Dr. Wolnei Caumo is a distinguished expert in the fields of anesthesia, pain management, and clinical research. As the Director of the Pain & Neuromodulation Laboratory at Hospital de Clínicas de Porto Alegre (HCPA) and Full Professor of Anesthesia and Pain at the Medical School of Universidade Federal do Rio Grande do Sul (UFRGS) in Porto Alegre, Brazil, he has made significant contributions to advancing the understanding and treatment of chronic pain conditions. Dr. Caumo’s research focuses on neurophysiological markers of pain processing, biomarkers of neuroplasticity in chronic pain, and therapeutic interventions such as pharmacological and non-invasive brain stimulation techniques. He is renowned for his dedication to education and mentorship, guiding numerous students and research fellows in pain management practices. Dr. Caumo’s work has earned him widespread recognition and respect, and he continues to lead innovative research efforts aimed at improving the lives of individuals living with chronic pain.

Profile:

Education:

  • M.D. from Universidade Federal de Pelotas, Brazil (1992)
  • Residency in Anesthesia at Hospital de Clínicas de Porto Alegre, Brazil (1994)
  • M.Sc. in Medicine from Universidade Federal do Rio Grande do Sul, Brazil (1997)
  • Specialist in Pain and Palliative Medicine from Universidade Federal do Rio Grande do Sul, Brazil (2000)
  • Ph.D. in Medicine with specialization in Pain from Universidade Federal do Rio Grande do Sul, Brazil (2001)
  • Clinical Research Course from Harvard Medical School, USA (2011)

Professional Experience:

Prof. Dr. Wolnei Caumo holds several prominent positions in the field of anesthesia, pain management, and research. He is currently serving as a Full Professor of Anesthesia and Pain at the Medical School of Universidade Federal do Rio Grande do Sul in Porto Alegre, Brazil, a position he has held since 2003. Additionally, he serves as the Head of Service in Pain and Palliative Care at Hospital de Clínicas de Porto Alegre, where he has been contributing since 2017. Dr. Caumo is also the Director of the Laboratory of Pain & Neuromodulation at the same hospital, a role he has held since 2009. Over the years, he has been actively involved in coordinating various academic programs, including the Specialized Medical Care for Pain and Palliative Medicine Course and the Graduate Program in Medical Sciences at Universidade Federal do Rio Grande do Sul. Furthermore, he has been a Coordinator of the Center and teacher assistance of the Course in Principles and Practice of Clinical Research at Harvard Medical School since 2012. Dr. Caumo’s dedication to education and research in pain management has made him a respected figure in the field, both nationally and internationally.

Research Interest:

Prof. Dr. Wolnei Caumo’s research interests primarily revolve around pain management and neuromodulation approaches. He is particularly focused on investigating the neurophysiological mechanisms underlying chronic pain processing, including central sensitization and cortical excitability. Dr. Caumo’s research aims to identify biomarkers of neuroplasticity in musculoskeletal chronic pain conditions and explore therapeutic interventions to counteract maladaptive neuroplasticity. Additionally, he is interested in the therapeutic potential of non-invasive brain stimulation techniques, such as transcranial direct current stimulation (tDCS) and transcranial magnetic stimulation (TMS), in modulating pain perception and improving clinical outcomes in patients with chronic pain syndromes. His work also encompasses the evaluation of pharmacological interventions and the development of personalized treatment approaches based on individual neurobiological profiles. Overall, Prof. Dr. Wolnei Caumo’s research endeavors contribute to advancing our understanding of pain mechanisms and developing innovative strategies for pain management.

Publication Top Noted:

“Cross-sectional and longitudinal analysis of conditioned pain modulation and pain in fibromyalgia: CPM as an effect modifier of pain changes over time”:

  • Authors: Castelo-Branco, L., Pacheco-Barrios, K., Cardenas-Rojas, A., Caumo, W., Fregni, F.
  • Journal: Physiotherapy Research International
  • Year: 2024
  • Volume: 29
  • Issue: 2
  • Pages: e2072

“Impact of multiple-session home-based transcranial direct current stimulation (M-HB-tDCS) on eating behavior in fibromyalgia: A factorial randomized clinical trial”:

  • Authors: Jornada, M.N.D., Antunes, L.C., Alves, C., P Silva, D., Caumo, W.
  • Journal: Brain Stimulation
  • Year: 2024
  • Volume: 17
  • Issue: 2
  • Pages: 152–162

“Efficacy of Home-Based Transcranial Direct Current Stimulation Over the Primary Motor Cortex and Dorsolateral Prefrontal Cortex in the Disability Due to Pain in Fibromyalgia: A Factorial Sham-Randomized Clinical Study”:

  • Authors: Caumo, W., Lopes Ramos, R., Vicuña Serrano, P., LS Torres, I., Fregni, F.
  • Journal: Journal of Pain
  • Year: 2024
  • Volume: 25
  • Issue: 2
  • Pages: 376–392

“Troponin elevation as a marker of short deterioration and one-year death in a high-risk surgical patient cohort in a low and middle-income country setting: a postoperative approach to increase surveillance”:

  • Authors: Stahlschmidt, A., Passos, S.C., Dornelles, D.D., Caumo, W., Ferreira, M.
  • Journal: Canadian Journal of Anesthesia
  • Year: 2023
  • Volume: 70
  • Issue: 11
  • Pages: 1776–1788

“Transcranial Direct Current Stimulation (tDCS) Promotes state-dependent Effects on Neuroinflammatory and Behavioral Parameters in rats Chronically Exposed to Stress and a Hyper-Palatable Diet”:

  • Authors: de Castro, J.M., de Freitas, J.S., Stein, D.J., Caumo, W., Torres, I.L.S.
  • Journal: Neurochemical Research
  • Year: 2023
  • Volume: 48
  • Issue: 10
  • Pages: 3042–3054

“Preemptive transcranial direct current stimulation induces analgesia, prevents chronic inflammation and fibrosis, and promotes tissue repair in a rat model of postoperative pain”:

  • Authors: Zancanaro, M., Stein, D.J., Lopes, B.C., Caumo, W., Torres, I.L.S.
  • Journal: Neuroscience Letters
  • Year: 2023
  • Volume: 813
  • Pages: 137407